Overview of recent drug discovery approaches for new generation leukotriene A₄ hydrolase inhibitors

ISSN： 1746-0441

Source： Expert Opinion on Drug Discovery, Vol.8, Iss.1, 2013-01, pp. : 49-63

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel leukotriene A₄ hydrolase inhibitors

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 1, 1999-01 ,pp. : 91-95

Informa Healthcare

Access to resources Recommend Favorite

Inhibitors of Leukotriene A4 (LTA4 ) Hydrolase as Potential Anti Inflammatory Agents

Current Pharmaceutical Design, Vol. 7, Iss. 3, 2001-02 ,pp. : 163-179

Bentham Science Publishers

Access to resources Recommend Favorite

Recent advances in the discovery and evaluation of fatty acid amide hydrolase inhibitors

By Deng Hongfeng

Expert Opinion on Drug Discovery, Vol. 5, Iss. 10, 2010-10 ,pp. : 961-993

Informa Healthcare

Access to resources Recommend Favorite

Ecto-Nucleotidase Inhibitors: Recent Developments in Drug Discovery

Mini Reviews in Medicinal Chemistry, Vol. 15, Iss. 1, 2015-01 ,pp. : 21-33

Bentham Science Publishers

Access to resources Recommend Favorite

Leukotriene A4 Hydrolase as a Target for Cancer Prevention and Therapy

Current Cancer Drug Targets, Vol. 4, Iss. 3, 2004-05 ,pp. : 267-283

Bentham Science Publishers

Access to resources Recommend Favorite